Abstract
N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2) have been prepared. Selected compounds 10, 14, 25, and 53 show sub-μM ADAMTS-5 potency and good selectivity over the related metalloproteases ADAMTS-4 (Aggrecanase-1), MMP-13, and MMP-12. Compound 53 shows a good balance of potent ADAMTS-5 inhibition, moderate CYP3A4 inhibition and good rat liver microsome stability. This series of compounds represents progress towards selective ADAMTS-5 inhibitors as disease modifying osteoarthritis agents. © 2008 Elsevier Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Gilbert, A. M., Bursavich, M. G., Lombardi, S., Georgiadis, K. E., Reifenberg, E., Flannery, C. R., & Morris, E. A. (2008). N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2). Bioorganic and Medicinal Chemistry Letters, 18(24), 6454–6457. https://doi.org/10.1016/j.bmcl.2008.10.065
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.